SI3074033T1 - Spojine za zdravljenje debelosti in postopki njihove uporabe - Google Patents
Spojine za zdravljenje debelosti in postopki njihove uporabeInfo
- Publication number
- SI3074033T1 SI3074033T1 SI201431046T SI201431046T SI3074033T1 SI 3074033 T1 SI3074033 T1 SI 3074033T1 SI 201431046 T SI201431046 T SI 201431046T SI 201431046 T SI201431046 T SI 201431046T SI 3074033 T1 SI3074033 T1 SI 3074033T1
- Authority
- SI
- Slovenia
- Prior art keywords
- obesity
- compounds
- treatment
- methods
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361908998P | 2013-11-26 | 2013-11-26 | |
| PCT/US2014/067393 WO2015081093A1 (en) | 2013-11-26 | 2014-11-25 | Compounds for the treatment of obesity and methods of use thereof |
| EP14816018.7A EP3074033B1 (en) | 2013-11-26 | 2014-11-25 | Compounds for the treatment of obesity and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3074033T1 true SI3074033T1 (sl) | 2019-03-29 |
Family
ID=52134396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201431046T SI3074033T1 (sl) | 2013-11-26 | 2014-11-25 | Spojine za zdravljenje debelosti in postopki njihove uporabe |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20160375039A1 (https=) |
| EP (1) | EP3074033B1 (https=) |
| JP (2) | JP6672157B2 (https=) |
| AU (2) | AU2014354831B2 (https=) |
| CA (1) | CA2931826C (https=) |
| CY (1) | CY1122551T1 (https=) |
| DK (1) | DK3074033T3 (https=) |
| ES (1) | ES2709976T3 (https=) |
| HR (1) | HRP20190219T1 (https=) |
| HU (1) | HUE042196T2 (https=) |
| LT (1) | LT3074033T (https=) |
| PL (1) | PL3074033T3 (https=) |
| PT (1) | PT3074033T (https=) |
| RS (1) | RS58422B1 (https=) |
| SI (1) | SI3074033T1 (https=) |
| SM (1) | SMT201900064T1 (https=) |
| TR (1) | TR201901299T4 (https=) |
| WO (1) | WO2015081093A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170209408A1 (en) * | 2014-04-03 | 2017-07-27 | The Children's Medical Center Corporation | Hsp90 inhibitors for the treatment of obesity and methods of use thereof |
| CN106008657B (zh) * | 2016-05-20 | 2017-11-21 | 天津中医药大学 | 苦蘵苦素i及提取方法及用途 |
| IT201800005336A1 (it) * | 2018-05-14 | 2019-11-14 | Composizioni per uso nel trattamento dell’obesità | |
| WO2021072139A1 (en) * | 2019-10-11 | 2021-04-15 | Massachusetts Institute Of Technology | Formulations for gastrointestinal delivery of oligonucleotides |
| CN113599502A (zh) * | 2021-07-22 | 2021-11-05 | 廖儒佳 | 一种醉茄素a和瘦素的组合物及其在制备预防和或治疗出血性脑卒中药物中的应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA791659B (en) | 1978-04-17 | 1980-04-30 | Ici Ltd | Process and apparatus for spraying liquid |
| GB8504253D0 (en) | 1985-02-19 | 1985-03-20 | Ici Plc | Electrostatic spraying apparatus |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
| US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
| US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
| US5827734A (en) | 1995-01-20 | 1998-10-27 | University Of Washington | Materials and methods for determining ob protein in a biological sample |
| US5532336A (en) | 1995-01-31 | 1996-07-02 | Eli Lilly And Company | Anti-obesity proteins |
| US5521283A (en) | 1995-01-31 | 1996-05-28 | Eli Lilly And Company | Anti-obesity proteins |
| US5552522A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| US5552523A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| US5552524A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| AU6028396A (en) | 1995-06-07 | 1996-12-30 | Amgen, Inc. | Ob protein compositions and method |
| JPH11508895A (ja) | 1995-06-30 | 1999-08-03 | イーライ・リリー・アンド・カンパニー | 糖尿病を処置する方法 |
| AU6688896A (en) | 1995-08-17 | 1997-03-12 | Amgen, Inc. | Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
| US6936439B2 (en) | 1995-11-22 | 2005-08-30 | Amgen Inc. | OB fusion protein compositions and methods |
| WO1997018833A1 (en) | 1995-11-22 | 1997-05-29 | Amgen Inc. | Methods of increasing lean tissue mass using ob protein compositions |
| AU2670897A (en) | 1996-04-04 | 1997-10-29 | Amgen, Inc. | Fibulin pharmaceutical compositions and related methods |
| JP2000514422A (ja) * | 1996-06-20 | 2000-10-31 | メルク エンド カンパニー インコーポレーテッド | 肥満のための遺伝子治療 |
| JP2001501177A (ja) | 1996-08-30 | 2001-01-30 | アムジエン・インコーポレーテツド | Ｏｂタンパク質受容体をアップレギュレートすることによりｏｂタンパク質に対する個体の感受性を増加させる方法 |
| CZ90999A3 (cs) | 1996-09-20 | 1999-06-16 | Hoechst Aktiengesellschaft | Farmaceutický přípravek obsahující antagonistu leptinu vhodný pro léčení inzulínové rezistence u diabetes mellitus II. typu |
| DE69730093T2 (de) | 1996-10-31 | 2006-07-20 | Takeda Pharmaceutical Co. Ltd. | Zubereitung mit verzögerter Freisetzung |
| WO1998028427A1 (en) | 1996-12-20 | 1998-07-02 | Amgen Inc. | Ob fusion protein compositions and methods |
| CN1202862C (zh) | 1997-04-17 | 2005-05-25 | 安姆根有限公司 | 包含具有抗体Fc链的稳定、有活性人OB蛋白的结合物的组合物及方法 |
| KR20010013414A (ko) | 1997-06-06 | 2001-02-26 | 피터 기딩스 | 당뇨병의 치료를 위한 렙틴 길항제의 용도 |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
| JP4199421B2 (ja) | 1998-08-10 | 2008-12-17 | アムジエン・インコーポレーテツド | デキストラン−レプチン結合体、医薬組成物および関連方法 |
| WO2000020872A1 (en) | 1998-10-02 | 2000-04-13 | Amgen Inc. | Method to determine a predisposition to leptin treatment |
| US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| ES2257287T3 (es) | 1999-02-12 | 2006-08-01 | Amgen Inc. | Composiciones de leptina glicosiladas y metodos relacionados. |
| PT2219031E (pt) | 2001-10-22 | 2013-05-17 | Amgen Inc | Uso de leptina para tratamento de lipoatrofia humana e método para determinar predisposição ao referido tratamento |
| WO2004039832A2 (en) | 2002-10-31 | 2004-05-13 | Albany Medical College | Leptin-related peptides |
| JP4585186B2 (ja) * | 2003-07-31 | 2010-11-24 | 杏林製薬株式会社 | 肥満、糖尿病及び脂質代謝異常の新規な予防又は治療剤 |
| CA2658959A1 (en) * | 2006-06-23 | 2007-12-27 | Laboratorios Del Dr. Esteve, S.A. | Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| US20110230551A1 (en) * | 2008-09-15 | 2011-09-22 | Leslie Gunatilaka | Withaferin a analogs and uses thereof |
| WO2010053655A2 (en) * | 2008-11-07 | 2010-05-14 | University Of Kansas | Therapeutic methods with withaferin a and analogs |
| US8598339B2 (en) * | 2011-02-01 | 2013-12-03 | University Of Kansas | Withanolide isolated from Physalis longifolia and analogs and methods of use thereof |
-
2014
- 2014-11-25 SI SI201431046T patent/SI3074033T1/sl unknown
- 2014-11-25 HR HRP20190219TT patent/HRP20190219T1/hr unknown
- 2014-11-25 PL PL14816018T patent/PL3074033T3/pl unknown
- 2014-11-25 LT LTEP14816018.7T patent/LT3074033T/lt unknown
- 2014-11-25 US US15/039,743 patent/US20160375039A1/en not_active Abandoned
- 2014-11-25 ES ES14816018T patent/ES2709976T3/es active Active
- 2014-11-25 TR TR2019/01299T patent/TR201901299T4/tr unknown
- 2014-11-25 PT PT14816018T patent/PT3074033T/pt unknown
- 2014-11-25 AU AU2014354831A patent/AU2014354831B2/en not_active Ceased
- 2014-11-25 SM SM20190064T patent/SMT201900064T1/it unknown
- 2014-11-25 JP JP2016554826A patent/JP6672157B2/ja active Active
- 2014-11-25 CA CA2931826A patent/CA2931826C/en active Active
- 2014-11-25 HU HUE14816018A patent/HUE042196T2/hu unknown
- 2014-11-25 RS RS20190124A patent/RS58422B1/sr unknown
- 2014-11-25 DK DK14816018.7T patent/DK3074033T3/en active
- 2014-11-25 WO PCT/US2014/067393 patent/WO2015081093A1/en not_active Ceased
- 2014-11-25 EP EP14816018.7A patent/EP3074033B1/en active Active
-
2018
- 2018-01-23 AU AU2018200517A patent/AU2018200517B2/en not_active Ceased
-
2019
- 2019-02-05 CY CY20191100155T patent/CY1122551T1/el unknown
- 2019-12-16 JP JP2019226600A patent/JP2020059744A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018200517A1 (en) | 2018-02-15 |
| CY1122551T1 (el) | 2021-01-27 |
| EP3074033B1 (en) | 2018-11-07 |
| TR201901299T4 (tr) | 2019-02-21 |
| AU2018200517B2 (en) | 2019-12-19 |
| WO2015081093A1 (en) | 2015-06-04 |
| ES2709976T3 (es) | 2019-04-22 |
| JP2016537431A (ja) | 2016-12-01 |
| US20160375039A1 (en) | 2016-12-29 |
| PT3074033T (pt) | 2019-02-08 |
| CA2931826C (en) | 2021-11-16 |
| AU2014354831A1 (en) | 2016-06-09 |
| HRP20190219T1 (hr) | 2019-03-22 |
| PL3074033T3 (pl) | 2019-08-30 |
| AU2014354831B2 (en) | 2017-10-26 |
| LT3074033T (lt) | 2019-02-25 |
| SMT201900064T1 (it) | 2019-02-28 |
| DK3074033T3 (en) | 2019-02-11 |
| HUE042196T2 (hu) | 2019-06-28 |
| EP3074033A1 (en) | 2016-10-05 |
| JP6672157B2 (ja) | 2020-03-25 |
| RS58422B1 (sr) | 2019-04-30 |
| CA2931826A1 (en) | 2015-06-04 |
| JP2020059744A (ja) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
| ZA201607415B (en) | Antibody-drug-conjugate and its use for the treatment of cancer | |
| GB201320729D0 (en) | Therapeutic compounds and their use | |
| IL244014A0 (en) | Combined therapy for the treatment of glioblastoma | |
| GB201320723D0 (en) | Composition and methods of treatment | |
| PT3021838T (pt) | Tratamento para a obesidade | |
| SG11201509782TA (en) | Compositions and methods for the treatment of diabetes and pre-diabetes | |
| GB201311361D0 (en) | Compounds and their therapeutic use | |
| SI2900230T1 (sl) | Sestavki za zdravljenje debelosti in postopki njihove uporabe | |
| IL247325A0 (en) | Therapeutic methods using noribogaine and related compounds | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| LT3074033T (lt) | Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdai | |
| GB201309375D0 (en) | Medical methods and compounds for medical use | |
| GB201308736D0 (en) | Compounds and their therapeutic use | |
| GB201309376D0 (en) | Medical methods and compounds for medical use | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| GB201308665D0 (en) | Device for the treatment of bone conditions | |
| AU2013900139A0 (en) | Device for the treatment of snoring | |
| GB201309379D0 (en) | Medical methods and compounds for medical use | |
| GB201317804D0 (en) | Therapeutic compounds and their use | |
| GB201316173D0 (en) | Compounds and their therapeutic use | |
| GB201307677D0 (en) | Compounds and their therapeutic use |